Table 2.
N | Incidence density (cases/100 person-years) |
Reduction in incidence* |
Number needed to treat |
||||
---|---|---|---|---|---|---|---|
Control | Intervention | % | 95% CI | n | 95% CI | ||
Overall | 550 | 14.2 | 9.8 | 32 | 7, 50 | 9.8 | 5.4, 53.9 |
Age, years† | |||||||
≤35 | 96 | 14.5 | 10.4 | 34 | −46, 70 | 4.0 | 2.1, 46.0 |
36–50 | 292 | 13.7 | 10.0 | 21 | −21, 49 | 13.9 | 5.4, −25.0 |
≥51 | 162 | 15.1 | 9.0 | 47 | 6, 70 | 10.1 | 4.0, −20.6 |
Sex† | |||||||
Male | 344 | 14.5 | 9.6 | 37 | 7, 58 | 9.2 | 4.7, 245.6 |
Female | 206 | 13.9 | 10.1 | 24 | −27, 54 | 12.0 | 4.6, −19.0 |
BMI, kg/m2† | |||||||
23 to <27.5 | 246 | 10.5 | 8.7 | 14 | −43, 48 | 46.3 | 10.9, −20.5 |
≥27.5 | 273 | 19.1 | 10.5 | 49 | 23, 66 | 6.8 | 4.3, 16.6 |
Prediabetes type† | |||||||
iIFG | 166 | 7.2 | 6.5 | 12 | −80, 57 | 15.5 | 7.8, 854.4 |
iIGT | 162 | 10.7 | 7.4 | 31 | −31, 64 | 11.0 | 5.4, −188.3 |
IFG+IGT | 222 | 22.2 | 14.5 | 36 | 3, 57 | 12.3 | 5.4, −43.6 |
HbA1c, % (mmol/mol)† | |||||||
<5.7 (<39) | 117 | 7.7 | 6.1 | 13 | −106, 64 | 19.3 | 7.9, −43.1 |
5.7–6.4 (39–46) | 340 | 15.3 | 8.1 | 50 | 25, 67 | 8.2 | 5.2, 19.6 |
≥6.5 (≥48) | 93 | 19.4 | 20.3 | −18 | −114, 35 | 256.4 | 5.9, −6.2 |
Family history† | |||||||
No | 200 | 12.8 | 7.3 | 46 | 5, 70 | 8.3 | 3.8, −55.5 |
Yes | 349 | 15.1 | 11.3 | 23 | −12, 47 | 10.8 | 5.1, −80.1 |
*Based on the hazard ratio.
†Tests for heterogeneity across strata were not statistically significant except for HbA1c (P = 0.05).